Estimating the burden of disease attributable to high cholesterol in South Africa in 2000

South African Medical Journal

Volumn 97, Issue 8, 2007, Pages 708-715

  Norman, Rosana ^a   Bradshaw, Debbie ^a   Steyn, Krisela ^b   Gaziano, Thomas ^c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INDIAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; POPULATION RESEARCH; RISK ASSESSMENT; SOUTH AFRICA; WORLD HEALTH ORGANIZATION; AGE DISTRIBUTION; COST OF ILLNESS; MIDDLE AGED; PREVALENCE; RACE; RISK FACTOR; SEX RATIO; STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CONTINENTAL POPULATION GROUPS; COST OF ILLNESS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SOUTH AFRICA;

EID: 38449116549     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
2. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
3. World Health Organization. The World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva: WHO, 2002.
4. Lawes CMM, Vander Hoorn S, Law MR, Rodgers A. High cholesterol. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative Quantification of Health Risks, Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: WHO, 2004: 391-496.
5. Ranjith N, Verho NK, Verho M, Winkelmann BR. Acute myocardial infarction in a young South African Indian-based population: patient characteristics on admission and genderspecific risk factor prevalence. Curr Med Res Opin 2002; 18: 242-248.
6. Walker AR. Changes in public health in South Africa from 1876. J R Soc Health 2001; 121: 85-93.
7. Seedat YK, Mayet FG. Risk factors leading to coronary heart disease among the black, Indian and white peoples of Durban. J Hum Hypertens 1996; 10: Suppl 3, S93-S94.
8. Pestana JA, Steyn K, Leiman A, Hartzenberg GM. The direct and indirect costs of cardiovascular disease in South Africa in 1991. S Afr Med J 1996; 86: 679-684.
9. Kruger HS, Venter CS, Vorster HH. Physical inactivity as a risk factor for cardiovascular disease in communities undergoing rural to urban transition: the THUSA study. Cardiovasc J S Afr 2003; 14: 16-23, quiz 23,28.
10. Mollentze WF, Moore AJ, Steyn AF, et al. Coronary heart disease risk factors in a rural and urban Orange Free State black population. S Afr Med J 1995; 85: 90-96.
11. Alberts M, Urban P, Steyn K, et al. Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovascular Prev Rehabil 2005; 12: 347-354.
12. Oelofse A, Jooste PL, Steyn K, et al. The lipid and lipoprotein profile of the urban black South African population of the Cape Peninsula - the BRISK study. S Afr Med J 1996; 86: 162-166.
13. Seedat YK, Mayet FGH, Latif GH, Joubert G. Risk factors and coronary heart disease in Durban blacks - the missing links. S Afr Med J 1992; 82: 251-256.
14. Steyn K, Jooste PL, Langenhoven ML, et al. Coronary risk factors in the coloured population of the Cape Peninsula. S Afr Med J 1985; 67: 619-625.
15. Steyn K, Levitt NS, Hoffman M, et al. The global cardiovascular disease risk pattern in a peri-urban working-class community in South Africa. The Mamre Study. Ethn Dis 2004; 14: 233-241.
16. Seedat YK, Mayet FGH, Khan S, Somers SR, Joubert G. Risk factors for coronary heart disease in the Indians of Durban. S Afr Med J 1990; 78: 447-454.
17. Seedat YK, Mayet FGH, Gouws E. Risk factors for coronary heart disease in the white community of Durban. S Afr Med J 1994; 84: 257-262.
18. Rossouw JE, Jooste PL, Chalton DO, et al. Community-based Intervention: The Coronary Risk Factor Study (CORIS). Int J Epidemiol 1993; 22: 428-438.
19. Steyn K, Steyn M, Swanepoel ASP, et al. Twelve-year results of the Coronary Risk Factor Study (CORIS). Int J Epidemiol 1997; 26: 964-971.
20. Ezzati M, Lopez A, Rodgers A, Vander Hoorn S, Murray C. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360.
21. Norman R, Bradshaw D, Schneider M, Pieterse D, Groenewald P. Revised Burden of Disease Estimates for the Comparative Risk Factor Assessment, South Africa 2000. http://www.mrc.ac.za/bod/bod.htm (last accessed 18 January 2007).
22. Asia-Pacific Cohort Studies Collaboration (APCSC). Determinants of cardiovascular disease in the Asia Pacific region: protocol for a collaborative overview of cohort studies. Cardiovascular Disease Prevention 1999; 2: 281-289.
23. World Health Organization. International Classification of Diseases and Related Health Conditions. 10th ed. Geneva: WHO, 1992.
24. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
25. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
26. Palisade Corporation. ®ISK software version 4.5 for Excel. New York: Palisade Corporation, 2002.
27. Maritz FJ. Dyslipidaemia in South Africa. In: Steyn K, Fourie J, Temple N, eds. Chronic Disease of Lifestyle in South Africa: 1995-2005. Technical Report. Cape Town: South African Medical Research Council, 2006.
28. Law MR. Plant sterol and stanol margarines and health. BMJ 2000; 320: 861-864.
29. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis. BMJ 2003; 326: 1423.
30. Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005; 365: 434-441.
31. Rogers A, Lawes CMM, Gaziano T, Vos T. The growing burden of risk from high blood pressure, cholesterol and bodyweight. In: Jamison DT, Breman JG, Measham AR, et al., eds. Disease Control Priorities in Developing Countries. 2nd ed. Washington, DC: Oxford University Press and The World Bank, 2006.
32. Koutkia P, Grinspoon S. HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies. Ann Rev Med 2004; 55: 303-317.
33. Calza L, Manfredi R, Chiodo F. Dyslipidaemia associated with antiretroviral therapy in HIVinfected patients. J Antimicrob Chemother 2004; 53: 10-14.
34. Barbaro G. Highly active antiretroviral therapy and the cardiovascular system: the heart of the matter. Pharmacology 2003; 69: 177-179.
35. Tershakovec AM, Frank I, Rader D. HIV-related lipodystrophy and related factors. Atherosclerosis 2004; 174: 1-10.
36. Sekhar RV, Jahoor F, Pownall HJ, Ballantyne CM, Balasubramanyam A. Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy. Curr Atheroscler Rep 2004; 6: 173-179.